Search results
Showing 16 to 30 of 50 results for leg ulcers
NICE has developed a Medtech Innovation Briefing (MIB) on Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers.
Evidence-based recommendations on Prontosan for treating acute and chronic wounds.
NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds .
NICE has developed a medtech innovation briefing (MIB) on MolecuLight i:X for wound imaging .
The Debrisoft monofilament debridement pad for use in acute or chronic wounds (HTG334)
Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds.
Evidence-based recommendations on subfascial endoscopic perforator vein surgery. This involves cutting and closing off, or heating and sealing, perforator veins so that blood can no longer go through them.
View recommendations for HTG32Show all sections
Sections for HTG32
Medical technologies guidance on UrgoStart for treating diabetic foot ulcers and leg ulcers (MTG42) Potential savings...
The MIST Therapy system for the promotion of wound healing (HTG267)
Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing.
Lower limb deep vein valve reconstruction for chronic deep venous incompetence (HTG141)
Evidence-based recommendations on lower limb deep vein valve reconstruction for chronic deep venous incompetence. This involves restructuring valves in the deep veins of the legs by various surgical techniques, such as using stitches to repair the valve.
View recommendations for HTG141Show all sections
Sections for HTG141
NICE has developed a Medtech Innovation Briefing (MIB) on the Versajet II hydrosurgery system
Discontinued Reference number: GID-TAG370
Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)
NICE has developed a medtech innovation briefing (MIB) on the Woundchek Protease Status for assessing elevated protease status in chronic wounds .
Evidence-based recommendations on radiofrequency ablation of varicose veins. This involves using radiofrequency energy to heat the wall of the vein so that it collapses.
View recommendations for HTG2Show all sections